CAS
PROK icon

CTC Alternative Strategies’s ProKidney PROK Stock Holding History

CTC Alternative Strategies’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.1K Buy
+13,453
New +$28.5K 0.05% 90

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CTC Alternative Strategies's PROK Position: Q1 2026 in Review

CTC Alternative Strategies opened a new position in ProKidney (PROK) in Q1 2026: 13,453 shares worth $24.1K. The stake represents 0.05% of the portfolio and ranks #90 among its holdings.

71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • CTC Alternative Strategies held 13,453 shares of ProKidney worth $24.1K as of Q1 2026.
  • ProKidney was a new CTC Alternative Strategies position in Q1 2026.
  • ProKidney made up 0.05% of CTC Alternative Strategies's portfolio in Q1 2026, its #90 holding.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on CTC Alternative Strategies's 13F filing for Q1 2026, filed 21 May 2026.